The store will not work correctly when cookies are disabled.
2-Methyl-3-(2-methylphenyl)-7-amino-4(3H)-quinazolinthione
ID: ALA1958381
PubChem CID: 57402724
Max Phase: Preclinical
Molecular Formula: C16H15N3S
Molecular Weight: 281.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccccc1-n1c(C)nc2cc(N)ccc2c1=S
Standard InChI: InChI=1S/C16H15N3S/c1-10-5-3-4-6-15(10)19-11(2)18-14-9-12(17)7-8-13(14)16(19)20/h3-9H,17H2,1-2H3
Standard InChI Key: LPNLAEAQCIKBGF-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
8.4812 -0.4291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4800 -1.2564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1949 -1.6693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1931 -0.0164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9083 -0.4255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9091 -1.2522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6243 -1.6632 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3393 -1.2484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3346 -0.4186 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.6187 -0.0113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0434 -0.0035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7607 -0.4133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4720 0.0028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4675 0.8286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7456 1.2365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0371 0.8180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6143 0.8135 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.7653 -1.6683 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0553 -1.6582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3191 1.2242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9 10 1 0
10 5 1 0
2 3 1 0
11 12 2 0
5 6 1 0
12 13 1 0
3 6 2 0
13 14 2 0
6 7 1 0
14 15 1 0
1 2 2 0
15 16 2 0
16 11 1 0
9 11 1 0
7 8 2 0
10 17 2 0
5 4 2 0
2 18 1 0
8 9 1 0
8 19 1 0
4 1 1 0
16 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 281.38 | Molecular Weight (Monoisotopic): 281.0987 | AlogP: 3.95 | #Rotatable Bonds: 1 |
Polar Surface Area: 43.84 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.76 | CX LogP: 3.23 | CX LogD: 3.23 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.54 | Np Likeness Score: -1.36 |
References
1. El-Azab AS, Eltahir KE.. (2012) Design and synthesis of novel 7-aminoquinazoline derivatives: antitumor and anticonvulsant activities., 22 (5): [PMID:22326394] [10.1016/j.bmcl.2012.01.071] |